With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

If you or your family and friends take some weight loss medications, you'll want to read this. Some users are reporting ...

The UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and ...

Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The ...

Health officials in the UK have launched a new study to investigate links between GLP-1 weight loss and diabetes drugs, like Ozempic, Wegovy, and Mounjaro, and serious pancreatic side effects, ...

The UK is studying cases of pancreatitis in people taking drugs based on GLP-1 receptor agonists for weight loss or type 2 ...

Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.

Mounjaro, also known as tirzepatide, works by regulating the user’s appetite by mimicking a naturally produced hormone called glucagon-like peptide-1 (GLP-1). When we eat, GLP-1 is released and ...

There are growing concerns about the side effects caused by weight loss injections such as Ozempic, Wegovy and Mounjaro.

An injectable weight-loss treatment is now available through primary care across the UK - and general practices across ...

GPs have been urged to be vigilant to signs of acute pancreatitis in patients who are taking GLP-1 weight-loss drugs.

Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...